InvestorsHub Logo
Followers 1
Posts 97
Boards Moderated 0
Alias Born 03/24/2009

Re: None

Tuesday, 11/07/2017 7:54:09 AM

Tuesday, November 07, 2017 7:54:09 AM

Post# of 8023
"Based on the expanding surgeon customer base and the increasing volume of MACI biopsies and implants, we believe that demand for MACI will far exceed that for Carticel. Given the MACI launch momentum and expanded patient access, we have initiated another sales force expansion in order to drive continued strong revenue growth in 2018 and beyond."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VCEL News